Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells.

Krüppel-like factor 6 (KLF6) is a DNA-binding protein containing a triple zinc-fingered motif and plays a key role in the regulation of cell proliferation, differentiation, and development. More recently it has been implicated in hepatic fibrosis via its binding to the transforming growth factor (TGF)-beta control element. In the kidney, epithelial-mesenchymal transition (EMT) is a major contributor to the pathogenesis of renal fibrosis, with TGF-beta1 being a key mediator of EMT. The present study aimed to determine the role of KLF6 and TGF-beta1 in EMT in proximal tubule cells. To determine the relevance in clinical disease, KLF6 was measured in kidneys of streptozotocin-induced diabetic Ren-2 rats and in cells exposed to high (30 mM) glucose. TGF-beta1 was confirmed to induce EMT by morphological change, loss of E-cadherin, and gain in vimentin expression. KLF6 mRNA expression was concomitantly measured. To determine the role of KLF6 in EMT, the above markers of EMT were determined in KLF6-silenced (small interfering RNA) and KLF6-overexpressing proximal tubule cells. KLF6 overexpression significantly promoted a phenotype consistent with EMT. High glucose induced KLF6 in proximal tubule cells (P < 0.05). This increase in KLF6 in response to high glucose was TGF-beta1 mediated. In an in vivo model of diabetic nephropathy KLF6 increased at week 8 (P < 0.05). KLF6 plays a permissive role in TGF-beta1-induced EMT in proximal tubule cells. Its upregulation in in vivo models of diabetic nephropathy suggests it as a potential therapeutic target.

[1]  S. Dhanasekaran,et al.  KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. , 2008, The Journal of clinical investigation.

[2]  E. Tham,et al.  Differential regulation of Krüppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: Effects of endothelin-1, oxidative stress and cytokines , 2008, Biochimica et biophysica acta.

[3]  S. Friedman,et al.  Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner. , 2008, Endocrinology.

[4]  Y. Kohgo,et al.  Dysregulation of systemic iron metabolism in alcoholic liver diseases , 2008, Journal of gastroenterology and hepatology.

[5]  D. Beer,et al.  A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. , 2008, Cancer research.

[6]  C. Balabaud,et al.  Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.

[7]  Yuan Zhang,et al.  High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. , 2007, The American journal of pathology.

[8]  A. Phillips,et al.  Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. , 2007, Experimental cell research.

[9]  L. Pradayrol,et al.  KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis , 2007, Cell Death and Differentiation.

[10]  S. Friedman,et al.  E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor , 2006, Oncogene.

[11]  S. Friedman,et al.  Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination , 2006, Clinical Cancer Research.

[12]  J. Fitzpatrick,et al.  TGF-beta1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. , 2006, American journal of physiology. Renal physiology.

[13]  N. Seeram,et al.  Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[14]  P. Devarajan,et al.  Induction of Zf9 in the kidney following early ischemia/reperfusion. , 2005, Kidney international.

[15]  S. Friedman,et al.  Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. , 2005, Cancer research.

[16]  S. Friedman,et al.  Frequent inactivation of the tumor suppressor Kruppel‐like factor 6 (KLF6) in hepatocellular carcinoma , 2004, Hepatology.

[17]  G. Ito,et al.  Krüppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.

[18]  S. Friedman,et al.  Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. , 2004, Gastroenterology.

[19]  C. Sempoux,et al.  Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. , 2003, Journal of hepatology.

[20]  H. Ha,et al.  Reactive oxygen species and matrix remodeling in diabetic kidney. , 2003, Journal of the American Society of Nephrology : JASN.

[21]  Y. Jeng,et al.  KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas , 2003, International journal of cancer.

[22]  D. Lovett,et al.  Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. , 2003, The American journal of pathology.

[23]  Junwei Yang,et al.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. , 2002, The Journal of clinical investigation.

[24]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[25]  S. Friedman,et al.  KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer , 2001, Science.

[26]  R. Atkins,et al.  Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). , 2001, The Journal of clinical investigation.

[27]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[28]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[30]  M. Cooper,et al.  Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. , 2000, Kidney international.

[31]  Allen M. Gown,et al.  Complete Chromogen Separation and Analysis in Double Immunohistochemical Stains Using Photoshop-based Image Analysis , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  S. Friedman,et al.  Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.

[33]  David W. Johnson,et al.  Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1 , 1998 .

[34]  K. Nath.  The tubulointerstitium in progressive renal disease. , 1998, Kidney international.

[35]  S. Friedman,et al.  Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  David A. Mankoff,et al.  Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.